Stock comparison
Alignment Healthcare
IDEXX Laboratories
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ALHC
Alignment Healthcare
Market cap
$3.38B
Sector
Healthcare
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ALHC | IDXX | Winner |
|---|---|---|---|
| Warren Buffett | 34F | 75B | IDXX |
| Benjamin Graham | 68D | 80A | IDXX |
| Philip Fisher | 46D | 75B | IDXX |
| Peter Lynch | 66B | 71B | IDXX |
| Joel Greenblatt | 43D | 83C | IDXX |
| Charlie Munger | 36D | 87A | IDXX |
| Terry Smith | 33F | 84A | IDXX |
Side-by-side metrics
| Metric | ALHC | IDXX |
|---|---|---|
| Market cap | $3.38B | $44.12B |
| P/E (TTM) | 186.4x | 39.0x |
| EV/EBIT | 178.7x | 31.6x |
| ROIC (TTM) | 5.88% | 40.66% |
| Gross margin | 12.38% | 62.05% |
| Net margin | 0.47% | 24.63% |
| Revenue CAGR 5y | 35.6% | 7.56% |
| EPS CAGR 5y | - | 10.79% |
| Debt / Equity | 1.6x | 0.7x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALHC leads on
- Revenue CAGR 5y35.6%vs 7.56%+79%
IDXX leads on
- Net margin24.63%vs 0.47%+98%
- Market cap$44.12Bvs $3.38B+92%
- ROIC (TTM)40.66%vs 5.88%+86%
- EV/EBIT31.6xvs 178.7x+82%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.